Company Overview - As of August 22, 2025, the stock price of Suobao Protein is 17.47 yuan, down 0.74% from the previous trading day, with a trading volume of 0.53 billion yuan [1] - The opening price for the day was 17.69 yuan, with a high of 17.69 yuan and a low of 17.34 yuan, resulting in a price fluctuation of 1.99% [1] - Suobao Protein's main business includes the research, production, and sales of soybean protein and related products, operating in industries such as agriculture, animal husbandry, and artificial meat [1] Market Activity - On August 22, a block trade occurred involving 1 million shares, amounting to 15.84 million yuan, which is a 9.33% discount compared to the closing price of the day [1] - This block trade accounted for 30.09% of the total trading volume on that day [1] - On the same day, there was a net inflow of 6.1969 million yuan from major funds, with a cumulative net inflow of 2.3684 million yuan over the past five trading days [1]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 8月22日，索宝蛋白收跌0.74%，收盘价为17.47元，发生1笔大宗交易，合计成交量100万股，成交金额 1584万元。 第1笔成交价格为15.84元，成交100.00万股，成交金额1,584.00万元，溢价率为-9.33%，买方营业部为中 信证券（山东）有限责任公司济南经七路证券营业部，卖方营业部为中信证券（山东）有限责任公司济 南经七路证券营业部。 进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为5960.64万元。该股近5个交易日累 计上涨1.57%，主力资金合计净流入359.78万元。 责任编辑：小浪快报 ...

| 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | | | | | | 中信证券(山东) | 中信证券(山东) | | 2025-08-22 | 索宝蛋白 | 603231 | 15.84 1584 | 100 | 有限责任公司济南 | 有限责任公司济南 | | | | | | | 47 11 | 47 LOUT *** 1 | 8月22日，索宝蛋白大宗交易成交100万股，成交额1584万元，占当日总成交额的23.13%，成交价15.84元，较市场收盘价17.47元折价9.33%。 ...

每经AI快讯，有投资者在投资者互动平台提问：请问贵司的生物科技膳食纤维产品产量销售情况如 何？ （文章来源：每日经济新闻） 索宝蛋白（603231.SH）8月19日在投资者互动平台表示，公司子公司万得福生物科技的膳食纤维项目 已建成投产，目前处于产能爬坡阶段，产能正稳步提升，公司全产业链协同发展优势更加凸显。 ...

格隆汇8月13日丨索宝蛋白(603231.SH)在投资者互动平台表示，公司主营业务为大豆蛋白系列产品的研 发、生产和销售，已构建起完整的非转基因大豆深加工产业链。公司暂未生产婴幼儿抗过敏大豆蛋白。 ...

Summary of Key Points Core Viewpoint - As of August 6, the margin financing and securities lending balance in the Shanghai and Shenzhen markets reached 2003.037 billion yuan, an increase of 9 billion yuan compared to the previous trading day, indicating a growing interest in leveraged trading [1]. Group 1: Market Overview - The financing balance was 1988.958 billion yuan, up by 8.68 billion yuan from the previous day [1]. - The Shanghai market's margin balance was 1023.066 billion yuan, increasing by 3.839 billion yuan, while the Shenzhen market's balance was 979.971 billion yuan, up by 5.161 billion yuan [1]. Group 2: Stock Performance - On August 6, 1930 stocks had net inflows of financing funds, with 71 stocks having net buy amounts exceeding 10% of their total trading volume [3]. - The top three stocks by net buy percentage were Diweier (32.68%), Suobodan (31.79%), and Hengtong Co. (27.57%) [4]. Group 3: Significant Net Inflows - A total of 20 stocks had net buy amounts exceeding 100 million yuan, with Haiguang Information, Boyuan Pharmaceutical, and Robot leading with net buys of 479 million yuan, 262 million yuan, and 248 million yuan, respectively [7].

Core Points - The company announced a cash dividend of 0.30 RMB per share for A shares, totaling 57,437,731.50 RMB based on a total share capital of 191,459,105 shares [1][2] - The profit distribution plan was approved at the annual general meeting held on May 15, 2025 [1] - The key dates for the dividend distribution include the record date on June 27, 2025, and the ex-dividend date on June 30, 2025 [1] Distribution Plan - The cash dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, after the market closes on the record date [1] - For shareholders with unrestricted circulating shares, the dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation [1] - Shareholders who have not completed designated transactions will have their dividends held by the China Securities Depository and Clearing Corporation until the designated transaction is completed [1] Taxation Information - Individual shareholders holding shares for more than one year will not be subject to personal income tax on the dividend, receiving the full 0.30 RMB per share [3] - For shares held for one year or less, the company will not withhold personal income tax at the time of distribution, but tax will be calculated and withheld upon the transfer of shares [3] - For shareholders holding restricted shares, a 10% withholding tax will apply, resulting in a net dividend of 0.27 RMB per share [4][6]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603231 证券简称：索宝蛋白 公告编号：2025-018 宁波索宝蛋白科技股份有限公司 2024年年度权益分派实施公告 重要内容提示： 每股分配比例 A 股每股现金红利0.30元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/27 | － | 2025/6/30 | 2025/6/30 | 差异化分红送转： 否 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 5 月 15 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 2. 自行发放对象 公司有限售条件流通股以及济南财金复星惟实股权投资基金合伙企业（有限合伙）、宁波 梅山保税港区复星 ...

Summary of Key Points Core Viewpoint - Shanghai Bunge Management Co., Ltd. has completed a share reduction plan, selling a total of 5,734,500 shares, which accounts for 3% of the company's total share capital, and has decided to terminate the reduction plan early [1][2][3] Group 1: Shareholder Information - Before the reduction plan, Shanghai Bunge held 7,179,715 shares, representing 3.75% of the company's total shares [2] - Shanghai Bunge has no other concerted actions or related parties involved in the shareholding [1] Group 2: Reduction Plan Implementation - The reduction plan was announced on April 23, 2025, with a planned reduction period from May 20, 2025, to August 19, 2025 [1] - The actual reduction included 1,914,500 shares sold through centralized bidding and 3,820,000 shares sold through block trading [2] - The total amount raised from the reduction was approximately 92,048,295 yuan, with a share price range of 15.52 to 17.05 yuan per share [2] Group 3: Current Shareholding Status - After the reduction, Shanghai Bunge holds 1,445,215 shares, which is 0.75% of the total share capital [2] - The reduction plan was consistent with the previously disclosed plan, and the actual reduction met the minimum required amount [3]

证券代码：603231 证券简称：索宝蛋白 公告编号：2025-017 宁波索宝蛋白科技股份有限公司 特定股东减持股份结果公告 公司于 2025 年 4 月 23 日在上海证券交易所网站（www.sse.com.cn）上披露 了《特定股东减持股份计划公告》（公告编号：2025-003），上海邦吉处于自身 经营发展需要，计划自公司关于减持计划公告披露之日起 15 个交易日后的 3 个 月内（即 2025 年 5 月 20 日至 2025 年 8 月 19 日期间），通过集中竞价或大宗交 易方式减持公司股份合计不超过 5,743,615 股，即不超过公司总股本的 3%。其 中，通过集中竞价交易方式减持不超过 1,914,500 股，即不超过公司总股本的 1%；通过大宗交易方式减持不超过 3,829,115 股，即不超过公司总股本的 2%。 若在减持计划期间公司有送股、配股等股份变动事项，减持股份数量相应调整； 若公司可转换公司债券转股、股权激励增发新股、非公开发行股票等引起的股份 变动事项，减持股份数量不做调整。 公司于 2025 年 5 月 29 日收到上海邦吉发来的《关于股份减持计划实施结果 的告知函》。截至 ...